Pfizer’s Legal Gambit in $9B Obesity Drug Battle
In a dramatic pharmaceutical showdown, Pfizer has filed a lawsuit against Novo Nordisk over a competing $9 billion bid for obesity drug developer Metsera. The legal battle signals intensifying competition in the lucrative weight loss treatment market.
